Issued Patents 2020
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10874687 | Highly active compounds against COVID-19 | Adel Moussa | 2020-12-29 |
| 10875885 | β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-29 |
| 10870672 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-22 |
| 10870673 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-12-22 |
| 10815266 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Adel Moussa | 2020-10-27 |
| 10758557 | Methods and compositions for treating hepatitis C virus | Paolo La Colla | 2020-09-01 |
| 10711029 | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection | Adel Moussa | 2020-07-14 |
| 10525072 | 2′-branched nucleosides and flaviviridae mutation | Paolo La Colla, David Standring, Vadim Bichko, Lin Qu | 2020-01-07 |